Skip to main content

Home/ Business News/ Group items tagged Phase IIb clinical trials

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Equities Group

RepliCel Converts Class C Shares to Common Stock | equities.com - 0 views

editorial.equities.com/...class-c-shares-to-common-stock

equities.com RepliCel REPCF life sciences Class C stock common stock hair regeneration Phase IIb clinical trials baldness cure pattern baldness female pattern baldness

shared by Equities Group on 01 Dec 11 - No Cached
  • Equities Group on 01 Dec 11
     
    RepliCel, which is currently testing their groundbreaking procedure for treating baldness, has converted 13 million shares of Class C stock into common stock.
1 - 1 of 1
Showing 20▼ items per page